Declaration of competing financial interests
From the following article:
Form to function: current and future roles for atherosclerosis imaging in drug development
Alistair C. Lindsay & Robin P. Choudhury
Nature Reviews Drug Discovery 7, 517-529 (June 2008)
doi:10.1038/nrd2588
Declaration: R.P.C. has received research funding from GlaxoSmithKline and Merck (Darmstadt) for work involving atherosclerosis imaging with MRI. He has received travel awards/honoraria/speaker fees from or served as a consultant or on advisory boards to Merck, Sanofi Aventis, AstraZeneca, GlaxoSmithKline, Schering–Plough, Solvay Healthcare and Pfizer. R.P.C.'s work is supported by the Oxford Biomedical Research Centre, NIHR funding scheme.
